192 related articles for article (PubMed ID: 21251197)
1. Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.
Lee KN; Jackson KW; Christiansen VJ; Dolence EK; McKee PA
J Thromb Haemost; 2011 May; 9(5):987-96. PubMed ID: 21251197
[TBL] [Abstract][Full Text] [Related]
2. Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.
Lee KN; Jackson KW; Terzyan S; Christiansen VJ; McKee PA
Biochemistry; 2009 Jun; 48(23):5149-58. PubMed ID: 19402713
[TBL] [Abstract][Full Text] [Related]
3. Why alpha-antiplasmin must be converted to a derivative form for optimal function.
Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
J Thromb Haemost; 2007 Oct; 5(10):2095-104. PubMed ID: 17883704
[TBL] [Abstract][Full Text] [Related]
4. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.
Lee KN; Jackson KW; Christiansen VJ; Chung KH; McKee PA
Blood; 2004 May; 103(10):3783-8. PubMed ID: 14751930
[TBL] [Abstract][Full Text] [Related]
5. Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis.
Uitte de Willige S; Malfliet JJ; Janssen HL; Leebeek FW; Rijken DC
J Thromb Haemost; 2013 Nov; 11(11):2029-36. PubMed ID: 24034420
[TBL] [Abstract][Full Text] [Related]
6. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein.
Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
Blood; 2006 Feb; 107(4):1397-404. PubMed ID: 16223769
[TBL] [Abstract][Full Text] [Related]
7. The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity.
Christiansen VJ; Jackson KW; Lee KN; McKee PA
Blood; 2007 Jun; 109(12):5286-92. PubMed ID: 17317851
[TBL] [Abstract][Full Text] [Related]
8. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.
Christiansen VJ; Jackson KW; Lee KN; McKee PA
Arch Biochem Biophys; 2007 Jan; 457(2):177-86. PubMed ID: 17174263
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
10. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
[TBL] [Abstract][Full Text] [Related]
11. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
Lee KN; Jackson KW; McKee PA
Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
[TBL] [Abstract][Full Text] [Related]
12. Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal.
Lee KN; Jackson KW; Christiansen VJ; Chung KH; McKee PA
Curr Med Chem Cardiovasc Hematol Agents; 2004 Oct; 2(4):303-10. PubMed ID: 15320781
[TBL] [Abstract][Full Text] [Related]
13. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
[TBL] [Abstract][Full Text] [Related]
14. TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots.
Mutch NJ; Thomas L; Moore NR; Lisiak KM; Booth NA
J Thromb Haemost; 2007 Apr; 5(4):812-7. PubMed ID: 17388801
[TBL] [Abstract][Full Text] [Related]
15. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.
Urano T; Ihara H; Takada Y; Fujie M; Takada A
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):145-53. PubMed ID: 10759007
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.
Jambunathan K; Watson DS; Endsley AN; Kodukula K; Galande AK
FEBS Lett; 2012 Jul; 586(16):2507-12. PubMed ID: 22750443
[TBL] [Abstract][Full Text] [Related]
17. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
Robbie LA; Booth NA; Croll AM; Bennett B
Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
[TBL] [Abstract][Full Text] [Related]
18. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the murine plasma fibrinolytic system.
Lijnen HR; van Hoef B; Beelen V; Collen D
Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
[TBL] [Abstract][Full Text] [Related]
20. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]